Target Healthcare REIT (LON:THRL) Sets New 12-Month High – What’s Next?

Target Healthcare REIT (LON:THRL)’s share price reached a new 52-week high during trading on Friday . The company traded as high as GBX 110 and last traded at GBX 108.80, with a volume of 43722 shares. The stock had previously closed at GBX 108.40.

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a “hold” rating and issued a GBX 101 price objective on shares of Target Healthcare REIT in a research note on Wednesday, May 6th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of GBX 101.

Target Healthcare REIT Price Performance

The firm has a market cap of £669.86 million, a price-to-earnings ratio of 8.59, a price-to-earnings-growth ratio of 1.48 and a beta of 0.53. The firm has a 50 day moving average price of GBX 103.73 and a 200-day moving average price of GBX 101.36.

Target Healthcare REIT (LON:THRL) last issued its quarterly earnings results on Wednesday, March 18th. The company reported GBX 3.38 earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 10.73% and a net margin of 104.45%. On average, sell-side analysts expect that Target Healthcare REIT will post 6.2219101 EPS for the current fiscal year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.